BMI View: The Czech pharmaceutical market is the most developed in terms of spending and ease ofoperation in the Central and Eastern European region, but it continues to present challenges fordrugmakers. Price erosion by regulatory agencies and blind bidding auctions drive prices down year-onyear.The open movement of goods and services in the European Union has given rise to an arbitrageopportunity for medicines, which certain businesses have exploited. While within the letter of the law, theimpact of parallel exports is felt by patients, who have reported shortages of vital medicines. Thisworrying trend is being seen across Central and Eastern Europe. We highlight th...
No comments:
Post a Comment